Nanoparticles hits cancer target in human patients

Researchers have demonstrated the first proof that a nanoparticle can target, enter and deliver small chunks of RNA that can turn off the production of cancer protein.

NCI Alliance for nanotechnology in cancer (National Cancer Institute):  Full media release here

April 2010

Reference

Nature 464, 1067-1070 (15 April 2010)

Davis, M, et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles